FDG better than FLT in diagnosing thyroid metastases

04/17/2013 | MolecularImaging.net

A study from Japan found that 18F-FDG performed better than 18F-FLT in diagnosing differentiated thyroid metastases and is more useful in assessing recurrence of postoperative differenti­ated thyroid cancer. In terms of per-patient detection, 18F-FDG showed 92% sensitivity and 86% specificity, compared with 18F-FLT's 69% sensitivity and 29% specificity. For detecting metastases to lymph nodes, FDG showed 85% sensitivity and 99.5% specificity, compared with 50% sensitivity and 90.7% specificity for FLT.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA